An innovative robotic surgery system is being developed by Cambridge Design Partnership (CDP) and Titan Medical.
The single-port robotic surgery system is being designed to offer minimally invasive surgery through a single incision, rather than several incisions, which is currently the case with both conventional laparoscopic surgery and existing multi-port robotic systems.
According to CDP, the solution could also offer swifter recovery time and less scarring for patients, in addition to better access to narrow spaces for surgeons.
Hans Pflaumer, senior mechanical engineer at CDP, said: “For a surgeon to achieve a good result with just a single small incision creates all sorts of technical and design challenges, which we have worked intensively to overcome.
“In the Titan robot, this is accomplished using a single 25mm port that is used to pass a 2D camera, a 3D camera and the multi-articulating instruments into the surgical site.”
Titan’s robotic surgery technology contains a large amount of intellectual property (IP), with 47 issued and 87 pending patents on individual elements within the system.
UK-headquartered technology and product development company CDP first started working with Canada-based Titan Medical on its robotic surgery system in 2019.
The two companies are now working together towards a submission for FDA approval in the USA, where CDP has a base in Raleigh, North Carolina.
CDP partner Jez Clements, added: “It’s a design-critical build that will ultimately revolutionise minimally invasive surgery.
“Ultimately, we are aiming for surgeons to use this equipment with complete confidence in the operating theatre.
“The market is ready for this innovation and it will undoubtedly bring huge benefits to patients in the future.”
